| Application no. and date | 10075429.0 (espacenet) (Federated) (European Patent Register), 20020716 | | Patent/reg. no. and date | DK/EP 2266968, 20130109 | | Publication date | 20101229 | | Priority no. and date | US 305814 P, 20010716 | | EP pub. no. and date |
EP 2266968 20101229 | | Effective date | | | Applicant/owner | GENZYME CORPORATION, 500 Kendall Street
Cambridge, MA 02142, US | | Applicant ref. no. | AVENTIS 5035EPEPD1 | | Inventor | Hirth, Bradford, 39 Foster Street
Littleton
Massachusetts 01460, US,
Siegel, Craig, 15 Bradford Road
Wobum
Massachusetts 01801, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 295/185 (2006.01) , C07D 319/18 (2006.01) , C07D 498/04 (2006.01) | | Title | Syntese af UDP-glucose: N-acylsphingosin-glucosyltransferase-hæmmere | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
